Can alcohol trigger psoriatic arthritis flares?

... psoriatic arthritis (PsA)1. CLINICAL DATA. IMPACT 2. ACR20 RESPONSE; Enthesitis; Dactylitis. At Week 14, significantly more patients receiving REMICADE® 5 mg/kg ... The purpose of this study is to evaluate the safety and efficacy of risankizumab in adults with moderately to severely active psoriatic arthritis (PsA). Jan 15, 2025 ... Secukinumab injection is used to treat moderate to severe plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) Jun 18, 2024 ... Psoriatic Arthritis · Raynaud's Syndrome · Reactive Arthritis · Rheumatoid ... Mateus highlighted data from Juvenile Arthritis Research, a ... Information about RINVOQ, a treatment for rheumatoid arthritis (RA) & other autoimmune diseases: What is it? How to take it? What are the side effects? Learn about dosing information of STELARA® (ustekinumab) for your patients, including administration information. See full prescribing and safety ... Psoriatic arthritis, in short called PsA, is a rheumatologic disease that effects about 1,5 million Americans. About one in three people with the skin disease ... When abatacept is given intravenously to treat rheumatoid arthritis or psoriatic arthritis ... information is provided for informational purposes only. The ... May 8, 2024 ... The aim of this study was to increase the screening of patients with PsO, and reduce the delay to diagnosis in PsA. Discover RINVOQ, a once-daily medication for active psoriatic arthritis (PsA). See full Prescribing & Safety Information, and Boxed Warning.